Tags: Goldman Sachs
Goldman cuts crude outlook and oil company forecasts
Goldman Sachs has cut its long-term crude oil price forecasts and recommended investors sell shares in two major oil companies, saying that improved U.S. shale efficiency and higher production from OPEC will more than cover future demand.
Syngenta rejects $45 billion Monsanto takeover offer
Agrochemicals firm Syngenta on Friday rejected a $45 billion takeover offer from Monsanto, saying the offer undervalued the Swiss firm and did not fully take into account regulatory risks.
Teva to buy U.S. drug developer Auspex Pharma for $3.5 billion
Israel's Teva Pharmaceutical Industries said it would buy U.S. neurology drug company Auspex Pharmaceuticals Inc for an equity value of $3.5 billion to boost its portfolio of treatments for the central nervous system.
Goldman climbs to top commodity bank ranking over JP Morgan LONDON
Goldman Sachs became the top commodities bank last year, overtaking rival JP Morgan, a consultancy said on Friday.